Eutilex Co.,Ltd.
Develops immunotherapeutics for cancers and autoimmune diseases via T-cell/antibody tech.
263050 | KO
Overview
Corporate Details
- ISIN(s):
- KR7263050007
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 금천구 가산디지털1로 58 408호 (가산동, 에이스한솔타워), 서울특별시
- Website:
- https://www.eutilex.com/en/
- Sector:
- Manufacturing
Description
Eutilex Co., Ltd. is a biotechnology company focused on the research and development of immunotherapeutics for cancers and autoimmune diseases. The company's core approach involves selecting targets that enhance or suppress human immune responses. Its pipeline is centered on three primary technology platforms: T-cell therapy, antibody therapy, and CAR-T cell therapy. Key development programs include adoptive T-cell therapies, such as those based on 4-1BB cytotoxic T lymphocytes (CTL), and various immunomodulatory antibody therapeutics designed to treat a range of incurable diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-03-14 00:00 |
[기재정정]의결권대리행사권유참고서류
|
Korean | 125.8 KB | ||
| 2024-03-14 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.7 KB | ||
| 2024-03-07 00:00 |
주주총회소집결의
|
Korean | 22.0 KB | ||
| 2024-03-07 00:00 |
주주총회소집공고
|
Korean | 143.8 KB | ||
| 2024-03-07 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.2 KB | ||
| 2024-03-07 00:00 |
의결권대리행사권유참고서류
|
Korean | 121.7 KB | ||
| 2024-03-07 00:00 |
기업설명회(IR)개최
|
Korean | 7.4 KB | ||
| 2024-02-13 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 10.8 KB | ||
| 2023-12-19 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인)(EU307(GPC3-IL18 CAR-T 치료제) 간세포암 대상 제1상 임상시험계획서 변경승인)
|
Korean | 14.6 KB | ||
| 2023-12-15 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.2 KB | ||
| 2023-11-20 00:00 |
기타경영사항(자율공시)(항-인간 4-1BB 항체 및 그의 용도에 대한 특허권 취득)
|
Korean | 6.0 KB | ||
| 2023-11-20 00:00 |
기타경영사항(자율공시)(항-인간 4-1BB 항체 및 그의 용도에 대한 특허권 취득)
|
Korean | 6.0 KB | ||
| 2023-11-14 00:00 |
분기보고서 (2023.09)
|
Korean | 1.4 MB | ||
| 2023-10-05 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인신청)(EU307(GPC3-IL18 CAR-T 치료제) 간세포암 대상 제1상 임상시험계획서 변경승인신…
|
Korean | 13.6 KB | ||
| 2023-08-14 00:00 |
반기보고서 (2023.06)
|
Korean | 1.2 MB |
Automate Your Workflow. Get a real-time feed of all Eutilex Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Eutilex Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Eutilex Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
